Search the Newsreel

Mangalore Refinery & Petrochemicals Ltd Sees Exceptional Volume Surge Amid Market Recovery

Reliance Chemotex re-appoints Sanjiv Shroff as MD for 3 years

Westlake Corporation $WLK Shares Sold by Sei Investments Co.

Sei Investments Co. significantly reduced its stake in Westlake Corporation (NYSE:WLK) during the first quarter by selling 15,673 shares, leaving them with 12,769 shares valued at $1.49 million. Despite institutional investors collectively owning 28.4% of WLK, analysts maintain a "Hold" rating with an average …

DMCC Standalone June 2026 Net Sales at Rs 252.99 crore, up 99.17% Y-o-Y

Will Chemtrade Logistics Income Fund (CHE-UN) Beat Earnings Estimates in Its Next Report?

DMCC Speciality Chemicals Q1 Net Profit Surges 163% to ₹20.4 Crore

AksharChem India General Manager Sunil Rane Retires

Air Products and Chemicals, Inc. (NYSE:APD) Receives Average Recommendation of "Moderate Buy" from Analysts

Analysts have issued a "Moderate Buy" consensus rating for Air Products and Chemicals (NYSE:APD), with an average 12-month price target of $332.76, exceeding its current share price of $307.61. The company recently surpassed quarterly earnings expectations, reporting an EPS of $3.47 and a 4.6% …

Vinyl Chemicals Share Price Today Up 9.02%: Stock Analysis

Is Westlake (WLK) Undervalued As Earnings Recovery Puts Its Valuation Back In Focus?

Westlake (WLK) is gaining investor attention after reporting a return to profitability in Q2 2026, driven by higher pricing, lower costs, and cost savings. While its stock has seen a recent rebound, its 3-year return remains negative, and conflicting valuation models exist. One popular …

If EPS Growth Is Important To You, J.G. Chemicals (NSE:JGCHEM) Presents An Opportunity

Chemours Co (CC) CFO Shane Hostetter Buys 3,350 Shares

Chemours Co's CFO, Shane Hostetter, recently purchased 3,350 shares of the company stock, signaling strong insider confidence. This transaction, executed at $14.94 per share, increases his direct ownership to over 102,000 shares. The stock is currently deemed "Modestly Undervalued" by GuruFocus's GF Value model, …

Chemours Co (NYSE: CC) CFO purchases 3,350 shares in open-market trade

Chemours Co's Chief Financial Officer, Shane Hostetter, purchased 3,350 shares of common stock on August 6, 2026, at a price of $14.94 per share. This transaction increased his total beneficial ownership to 102,697.7058 shares, including restricted stock units and dividend equivalent units. The purchase …

Chemours Co (CC) CFO withholds 3,087 shares to satisfy tax obligations

Chemed Corp VP Brian C. Judkins Executes Stock Option Exercise and Sells Shares on August 10, 2026

Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp (NYSE: CHE), filed a Form 4 on August 10, 2026. The filing discloses that Judkins exercised stock options and subsequently disposed of shares on the same date.

Chemed Corp (CHE) legal chief exercises 6,786 options, withholds 5,878 shares

Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp (CHE), exercised stock options for 6,786 shares at an exercise price of $445.35 per share. To cover the purchase and tax obligations, 5,878 shares were withheld at $548.96 per share. Following this transaction, …

Westlake Corp (WLK) director exercises 2,168 RSUs into common stock

Westlake Corp director Kimberly S. Lubel converted 2,168 restricted stock units (RSUs) into common stock on August 8, 2026. This transaction increased her direct holdings of common stock to 13,821 shares. The RSUs were granted on August 8, 2025, and vested on their first …

Westlake Corp (WLK) director exercises 2,168 RSUs, boosting holdings to 5,748 shares

Westlake Corp Director Carolyn Chao Sabat exercised 2,168 Restricted Stock Units (RSUs), converting them into common stock. This transaction increased her direct holdings in Westlake common stock to 5,748 shares. The RSUs were originally granted on August 8, 2025, and vested on their first …

Chemours' Medium-Term Growth Less Certain as Refrigerant Business Sees Larger Destocking, UBS Says

Chemours' (CC) recent financial results have cast less certainty on its medium-term growth, with its refrigerant business seeing larger destocking in the quarter, UBS said in a note emailed Monday.The company's refrigerant business gained temporary market share with an oversell Silver Upgrade to read …

The Chemours Company Launches Opteon Ze and Opteon 515B Refrigerants for Chiller Applications

The Chemours Company has introduced two new low-global warming potential (GWP) refrigerants, Opteon ZE and Opteon 515B, for stationary chiller applications. These products are designed to meet the increasing cooling demands of large-scale infrastructure, including data centers, driven by the growth of AI and …

Chemomab Therapeutics (CMMB) holder Erik Otto reports 1.2% ADS ownership

Erik Otto, an investor in Chemomab Therapeutics Ltd. (CMMB), has filed an amended Schedule 13G, disclosing beneficial ownership of 90,000 American Depository Shares (ADSs), which represents 1.2% of the company's outstanding ADSs. Each ADS represents twenty ordinary shares. Otto holds sole voting and dispositive …

Did Chemed's (CHE) Dividend Hike and Earnings Beat Just Shift Its Capital Allocation Narrative?

Par Drugs & Chemicals Ltd is Rated Hold

Chemours downgraded at UBS as refrigerants reset clouds outlook

[Petrochemical Plant Illuminated at Dusk] Bim/E+ via Getty Images UBS downgraded Chemours (CC [https://seekingalpha.com/symbol/CC]) to Neutral from Buy and slashed its price target, saying a sharper-than-expected reset in the chemical maker’s refrigerants business has reduced confidence in its medium-term growth outlook. Shares of Chemours …

DMCC Speciality Chemicals consolidated net profit rises 162.89% in the June 2026 quarter

Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments

New additions to the Opteon™ portfolio support high-performance, sustainable cooling solutions in stationary chillers for AI-driven data centers, and commercial HVAC applications WILMINGTON, Del., Aug. 10, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the launch of …

Don't Buy The Chemours Company (NYSE:CC) For Its Next Dividend Without Doing These Checks

The Chemours Company (NYSE:CC) is set to trade ex-dividend soon, with a payment of US$0.0875 per share, resulting in a 2.2% trailing yield. While the dividend is well-covered by free cash flow (25% payout), the company reported a loss last year and has shown …

ChemoMetec enters collaboration agreement with Roche Diagnostics

Chemometec A/S ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties' solutions in the field of bioprocess monitoring, ChemoMetec and Roche Diagnostics have today …

Chemring Group (LON:CHG) Given New GBX 680 Price Target at Royal Bank Of Canada

ICL Group (ICL) Reaffirmed Guidance And Unveiled Elevate, Is It Undervalued?

ICL Group (ICL) recently reaffirmed its full-year guidance, unveiled its "Elevate" cost program, and declared a dividend after reporting Q2 2026 results. Despite a short-term rebound in share price, the stock is still down 12.10% over the last year. While its P/E ratio is …

Indo Borax & Chemicals Q1FY27 net profit surges 62% to ₹162.5 crore

Chemed Corporation $CHE Shares Sold by Quantinno Capital Management LP

Quantinno Capital Management LP significantly reduced its stake in Chemed Corporation (NYSE:CHE) by 55.5% in the first quarter, selling 8,251 shares but still retaining 6,603 shares valued at approximately $2.49 million. This comes as Chemed reported strong quarterly earnings, beating estimates with EPS of …

Tiande Chemical Sets August Board Meeting to Approve Interim Results and Possible Dividend

IOL Chemicals & Pharmaceuticals clears June quarter unaudited results with clean review

Bodal Chemicals Standalone June 2026 Net Sales at Rs 698.30 crore, up 56.97% Y-o-Y

Chemours Company (The) Stock 12‑Month Price Target Cut to $22.5, Implies 43% Upside

The average 12-month price target for Chemours Company (The) stock has been revised down to $22.5 from $22.8, based on estimates from 10 analysts. This updated target suggests a potential upside of approximately 43% from the August 7 closing price. Despite the target cut, …